A large population-based pilot study led by researchers at the American Cancer Society and NCI shows cost discussions were infrequently documented in medical records of patients diagnosed with advanced non-small cell lung cancer and melanoma, which may hinder identifying patient financial needs and tracking outcomes of associated referrals.
The first large cancer screening/early detection initiative to be launched in 2025—the NCI-funded Vanguard study of multi-cancer detection tests—has started accruing patients through nine sites across the U.S.
